Hong Kong-listed AIM Vaccine (06660) schedules 30 March 2026 board meeting to approve FY2025 results and consider final dividend

Bulletin Express

03/18

The board of AIM Vaccine Co., Ltd. (Stock Code: 06660) has fixed Monday, 30 March 2026 for its next meeting. According to the company’s announcement filed with Hong Kong Exchanges and Clearing Limited, directors will review and approve the consolidated annual results for the financial year ended 31 December 2025. The agenda also includes discussion of a potential final dividend recommendation and other routine business matters.

The notice was issued by Chairman and CEO Mr. Yan Zhou on 18 March 2026. The current board comprises five executive directors—Mr. Yan Zhou, Mr. Xin Zhou, Mr. Shaojun Jia, Mr. Wen Guan and Mr. Jie Zhou—alongside one non-executive director, Mr. Jichen Zhao, and three independent non-executive directors, Professor Ker Wei Pei, Ms. Jie Wen and Mr. Xiaoguang Guo.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1182577465"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1182577465\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1182577465?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-18 16:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182577465","market":"hk","top_or_hot":-1,"title":"Hong Kong-listed AIM Vaccine (06660) schedules 30 March 2026 board meeting to approve FY2025 results and consider final dividend","media":"Bulletin Express","content":"<p>The board of AIM Vaccine Co., Ltd. (Stock Code: 06660) has fixed Monday, 30 March 2026 for its next meeting. According to the company’s announcement filed with Hong Kong Exchanges and Clearing Limited, directors will review and approve the consolidated annual results for the financial year ended 31 December 2025. The agenda also includes discussion of a potential final dividend recommendation and other routine business matters.</p>\n<p>The notice was issued by Chairman and CEO Mr. Yan Zhou on 18 March 2026. The current board comprises five executive directors—Mr. Yan Zhou, Mr. Xin Zhou, Mr. Shaojun Jia, Mr. Wen Guan and Mr. Jie Zhou—alongside one non-executive director, Mr. Jichen Zhao, and three independent non-executive directors, Professor Ker Wei Pei, Ms. Jie Wen and Mr. Xiaoguang Guo.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong-listed AIM Vaccine (06660) schedules 30 March 2026 board meeting to approve FY2025 results and consider final dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong-listed AIM Vaccine (06660) schedules 30 March 2026 board meeting to approve FY2025 results and consider final dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-18 16:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The board of AIM Vaccine Co., Ltd. (Stock Code: 06660) has fixed Monday, 30 March 2026 for its next meeting. According to the company’s announcement filed with Hong Kong Exchanges and Clearing Limited, directors will review and approve the consolidated annual results for the financial year ended 31 December 2025. The agenda also includes discussion of a potential final dividend recommendation and other routine business matters.</p>\n<p>The notice was issued by Chairman and CEO Mr. Yan Zhou on 18 March 2026. The current board comprises five executive directors—Mr. Yan Zhou, Mr. Xin Zhou, Mr. Shaojun Jia, Mr. Wen Guan and Mr. Jie Zhou—alongside one non-executive director, Mr. Jichen Zhao, and three independent non-executive directors, Professor Ker Wei Pei, Ms. Jie Wen and Mr. Xiaoguang Guo.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06660","symbol_name":"艾美疫苗","start_time":0,"source_url":"","article_id":"1182577465","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182577465","pubTimestamp":1773823254,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"The board of AIM Vaccine Co., Ltd. (Stock Code: 06660) has fixed Monday, 30 March 2026 for its next meeting. According to the company’s announcement filed with Hong Kong Exchanges and Clearing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06660":"艾美疫苗"},"translate_title":"香港上市AIM疫苗(06660)定于2026年3月30日召开董事会批准2025财年业绩并考虑末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06660":1},"content_text":"The board of AIM Vaccine Co., Ltd. (Stock Code: 06660) has fixed Monday, 30 March 2026 for its next meeting. According to the company’s announcement filed with Hong Kong Exchanges and Clearing Limited, directors will review and approve the consolidated annual results for the financial year ended 31 December 2025. The agenda also includes discussion of a potential final dividend recommendation and other routine business matters.\nThe notice was issued by Chairman and CEO Mr. Yan Zhou on 18 March 2026. The current board comprises five executive directors—Mr. Yan Zhou, Mr. Xin Zhou, Mr. Shaojun Jia, Mr. Wen Guan and Mr. Jie Zhou—alongside one non-executive director, Mr. Jichen Zhao, and three independent non-executive directors, Professor Ker Wei Pei, Ms. Jie Wen and Mr. Xiaoguang Guo.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}